Clinical Trial Update: 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial investigating 68Ga-RM2 PET/MRI in biochemically recurrent prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• 68Ga-RM2

Snippet

Sponsor: Andrei Iagaru | Conditions: Prostate Adenocarcinoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-04-10